Recipharm AB Aktie [WKN DE: A111D5 / ISIN: SE0005757267]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Recipharm AB (B)

10.11.16		Recipharm AB: Interim report January-September 2016 (Businesswire)
07.11.16		Invitation to Presentation of Recipharm’s Interim Report for the Third Quarter 2016 on the 10th November (Businesswire)
29.09.16		Recipharm Successfully Places SEK 1,000M Senior Unsecured Convertible Bonds (Businesswire)
29.09.16		Recipharm AB: Recipharm launches a senior unsecured convertible bond issue of approximately SEK 1,000m (Businesswire)
22.07.16		Recipharm AB: Interim report January-June 2016 (Businesswire)
18.07.16		Invitation to Presentation of Recipharm’s Interim Report for the Second Quarter 2016 on the 22nd July (Businesswire)
30.06.16		Change in the total number of shares and votes in Recipharm AB (publ) (Businesswire)
13.06.16		Recipharm’s Rights Issue Fully Subscribed (Businesswire)
31.05.16		Change in the Total Number of Shares and Votes in Recipharm AB (publ) (Businesswire)
23.05.16		Recipharm AB: Recipharm completes acquisition of Kemwell AB and Cirrus Pharmaceuticals Inc. and resolve on share issues (Businesswire)
18.05.16		The Board of Directors of Recipharm resolves on a rights issue of approximately SEK 805 million and announces terms (Businesswire)
11.05.16		Bulletin from Extraordinary General Meeting of Recipharm AB (Publ) (Businesswire)
29.04.16		Bulletin from Annual General Meeting in Recipharm AB (publ) (Businesswire)
28.04.16		Recipharm AB: Interim report January-March 2016 (Businesswire)
26.04.16		Recipharm AB: Invitation to presentation of Recipharm’s interim report for the first quarter 2016 on the 28th April (Businesswire)
18.04.16		Notice to Attend the Extra Ordinary General Meeting of Recipharm AB (publ) (Businesswire)
18.04.16		Recipharm AB: Recipharm creates a global CDMO leader through SEK 1.7 billion strategic acquisitions in the US, Sweden and India (Businesswire)
11.04.16		Recipharm AB: Recipharm completes acquisition of a majority stake in Indian CMO Nitin Lifesciences (Businesswire)
05.04.16		Recipharm AB: Recipharm Publishes Annual Report 2015 (Businesswire)
31.03.16		Change in the total number of shares and votes in Recipharm AB (publ) (Businesswire)
30.03.16		Notice to attend the Annual General Meeting of Recipharm AB (Publ) (Businesswire)
03.03.16		Recipharm AB: Announcement from the Nomination Committee Concerning the Annual General Meeting 2016 (Businesswire)
29.02.16		Change in the Total Number of Shares and Votes in Recipharm AB (publ) (Businesswire)
24.02.16		Recipharm AB: Full Year report January - December 2015 (Businesswire)
23.02.16		Recipharm AB: Recipharm to acquire Mitim Srl for SEK 640 million adding scale and niche technology in injectable beta lactams (Businesswire)
22.02.16		Recipharm AB: Invitation to Presentation of Recipharm’s Full Year Report for 2015 on the 24th February (Businesswire)
26.01.16		Recipharm AB: Recipharm completes a directed issue of 2.25 million Class B shares, raising proceeds of approximately SEK 276 million (Businesswire)
15.01.16		Recipharm AB: Regulatory approval received for acquisition of Nitin Lifesciences (Businesswire)
21.12.15		Recipharm Signs Manufacturing Agreement with Alcon and Acquires Facility in France, Adding New Niche Capabilities (Businesswire)
05.11.15		Recipharm AB: Interim Report January - September 2015 (Businesswire)
03.11.15		Recipharm AB: Invitation to presentation of Recipharm’s interim report for the third quarter on 5 November 2015 (Businesswire)
20.10.15		Recipharm to Acquire Majority Stake in Indian CMO Nitin Lifesciences Creating Emerging Markets Platform (Businesswire)
08.10.15		Recipharm AB: Recipharm announces cost and efficiency program in Sweden (Businesswire)
07.09.15		Recipharm In Discussions with Alcon Regarding Long-Term Manufacturing Agreement (Businesswire)
31.07.15		Change in the Total Number of Shares and Votes in Recipharm AB (publ) (Businesswire)
23.07.15		Recipharm AB: Interim Report January-June 2015 (Businesswire)
30.06.15		Change in the Total Number of Shares and Votes in Recipharm AB (publ) (Businesswire)
15.06.15		Recipharm Acquires OnTarget Chemistry and Extends Its Offering into Preclinical Development Services (Businesswire)
01.06.15		Recipharm AB: Recipharm appoints Chief Strategy Officer (Businesswire)
07.05.15		Recipharm AB: Interim Report January-March 2015 (Businesswire)
04.05.15		Recipharm AB: Invitation to Presentation of Recipharm’s Interim Report for the First Quarter on 7 May 2015 (Businesswire)
16.04.15		Recipharm AB: Recipharm Publishes Annual Report 2014 (Businesswire)
14.04.15		Recipharm Makes Strategic Investment in Synthonics and Partners in Development of Novel Compounds (Businesswire)
08.04.15		Notice to Attend the Annual General Meeting of Recipharm AB (Publ) (Businesswire)
08.04.15		Recipharm AB: Announcement from the nomination committee concerning the Annual General Meeting 2015 (Businesswire)
27.02.15		Change in the total number of shares and votes in Recipharm AB (publ) (Businesswire)
19.02.15		Recipharm AB: Full-Year-report January-December 2014 (Businesswire)
16.02.15		Recipharm AB: Invitation to Presentation of Recipharm’s Full-Year-Report for 2014 on 19 February 2015 (Businesswire)
30.01.15		Change in the Total Number of Shares and Votes in Recipharm AB (Publ) (Businesswire)
22.01.15		Recipharm Releases the Lock-up on 815,000 B-Shares Related to Shares to Be Issued upon Conversion of Convertible Bonds (Businesswire)

1 | Weiter

Newssuche

Meistgelesene Nachrichten

Avance Gas Holding Ltd: Mandatory notification of trade by primary insiders

Experte schlägt Alarm: Platzt die Tesla-Blase schneller als gedacht?

Rheinmetall-Aktie und HENSOLDT-Aktie klettern weiter - Rekord

Bitcoin & Co.: "Dr. Doom" Roubini prognostiziert Krypto-Blase und warnt Anleger

Amazon-Aktie leichter: VKI-Erfolg gegen mehrere Geschäftsbedingungen von Amazon Prime

RENK-Aktie zieht an: Warburg Research nimmt RENK mit 'Buy' in Bewertung auf

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	20.02.2025 10:05
Kaufwert:	EUR
	Hinzufügen Speichern